Malaria No More
Malaria No More is a Washington, D.C.–based 501(c)(3) nonprofit that mobilizes U.S. and global policy commitment, funding, and innovation to end malaria, operating field programs in endemic countries and hosting IMACS, an AI-driven disease forecasting subsidiary.
- Company typePrivate
- Founded2006
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Malaria No More does
Malaria No More is a 501(c)(3) nonprofit organization founded in 2006 and headquartered in Washington, D.C. that mobilizes political commitment, sustained funding, and innovation to end malaria. Its work spans U.S. policy and advocacy with Congress and presidential administrations, global policy engagement in donor and endemic countries, and strategic communications — including congressional testimony that contributed to a $795 million FY 2026 U.S. bilateral malaria appropriation and a $4.6 billion U.S. pledge to the Global Fund. The organization operates through wholly-owned subsidiary IMACS (Institute for Health Modeling and Climate Solutions), which develops AI-driven forecasting and surveillance tools (SPECTRA, a WHO-Casebook-recognized multi-disease model, and a Bangladesh-deployed Climate-Informed Early Warning Surveillance System), and through regional affiliate Malaria No More Japan and a jointly controlled Health Finance Coalition that mobilizes catalytic capital via the Asian Development Bank's ExCITD platform.
The organization runs three core go-to-market motions: a policy-and-advocacy motion engaging U.S. and global policymakers; a community-led motion supporting field programs (SMC campaigns, community health worker training, malaria diagnosis improvement) through implementing partners such as PATH under PMI REACH Malaria; and an event-driven convening motion at World Malaria Day, the World Health Assembly, TICAD, and Hudson Institute panels. Revenue comes from tax-deductible donations (individual, corporate, foundation), government and institutional grants (PMI, Global Fund, Gates Foundation, Patrick J. McGovern Foundation, Amazon Environmental Equity), and specialized grants such as the NASA-funded Indonesia forecasting project. Malaria No More is governed by an independent board (now including former U.S. Global Malaria Coordinator RADM Timothy Ziemer) and led by CEO Dr. William Steiger, who succeeded Martin Edlund in December 2025.
Malaria No More firmographics
Firmographics- Name
- Malaria No More
- Legal name
- Malaria No More Fund
- Website
- https://malarianomore.org
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Malaria No More is a Washington, D.C.–based 501(c)(3) nonprofit that mobilizes U.S. and global policy commitment, funding, and innovation to end malaria, operating field programs in endemic countries and hosting IMACS, an AI-driven disease forecasting subsidiary.
- Ownership category
- akta.pro rank
Malaria No More industry classification
Industry- Product category
- Global Health Advocacy
- NAICS
- Voluntary Health Organizations (813212), Human Rights Organizations (813311)
- SIC
- Services-Membership Organizations (8600)
- akta.pro primary industry
- Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs) (HLAJAOAE)
- akta.pro secondary industries
- Disease-Specific Global Programs (HIV/TB/Malaria/NTDs) (HLAJAKAF), International & Local Implementing NGOs (HLAJAKAD), Vector-Borne Disease Surveillance & Control (HLAJABAG), Communicable Disease Prevention & Control (HIV/AIDS, TB, Malaria, NTDs) (BPADAIAA)
Keywords
Where Malaria No More is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Malaria No More business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Tax-Deductible Donations: Malaria No More is a 501(c)(3) nonprofit organization that raises funds from individual donors, corporations, and foundations. Donations are tax-deductible to the extent allowed under applicable law. The organization accepts donations via credit/debit cards, checks, donor-advised funds, and workplace giving programs.
- Government and Institutional Grants: Malaria No More receives funding and programmatic support from government entities including the U.S. President's Malaria Initiative, the Global Fund, and other bilateral and multilateral donors. The organization also partners with foundations such as the Gates Foundation and the Patrick J. McGovern Foundation for specific initiatives like IMACS.
Go-to-market motion4 records
Distribution channels3 records
Marketing channels9 records
Malaria No More product offering
Product offeringCore offering
Malaria No More is a 501(c)(3) nonprofit advocacy organization that mobilizes political commitment, funding, and innovation to end malaria. It delivers U.S. and global policy advocacy, strategic communications campaigns, field implementation support (such as PMI REACH), and operates the IMACS technology platform with the SPECTRA AI forecasting model and Climate-Informed Early Warning Surveillance Systems to accelerate malaria elimination in endemic countries.
Product overview
Malaria No More is a non-profit advocacy organization (501(c)(3)) focused on mobilizing political commitment, funding, and innovation to end malaria. The organization does not offer commercial software products or technology platforms. Its activities center on policy and advocacy campaigns, strategic communications, coalition building, and supporting partner organizations in malaria-endemic countries. The organization operates programs including US and global policy advocacy, strategic communications campaigns, and supports affiliated initiatives such as the Institute for Health Modeling and Climate Solutions (IMACS), though these are programmatic activities rather than commercial product offerings.
Differentiator
Problem solved
Functional benefit
Brands
- Institute for Health Modeling and Climate Solutions (IMACS): A global center of excellence dedicated to developing AI-informed predictive tools and strategies that enable systems strengthening at the intersection of climate change and infectious diseases.
- SPECTRA
Products and services
- U.S. Policy and Advocacy
- Global Policy and Advocacy
- Strategic Communications Campaigns
- SPECTRA AI Disease Forecasting Model
Quantifiable outcome
- 14 million lives saved since 2000
- +6 more outcomes
Companies that use Malaria No More
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Malaria No More technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Malaria No More partnerships and signals
Strategic signalPartnerships
27 partnerships are on record, tiered major, core and minor.
- University of Maryland (UMD)majorIMACS joined a NASA-funded project led by UMD (Professor Tatiana Loboda) to develop a malaria and dengue forecasting model for Indonesia using satellite-based environmental monitoring, advanced health modeling, and AI. Grant amount: $1,093,841 from NASA's Earth Science Division.
- Asian Development Bank (ADB)coreMalaria No More and the Health Finance Coalition signed an MoU with ADB to launch the ExCITD (Ending Complex and Challenging Infectious and Tropical Diseases) platform, aiming to mobilize financing to help Asia-Pacific countries scale innovation for malaria, dengue, and tuberculosis elimination.
- AbbottcoreAbbott and Malaria No More signed an agreement with the Government of Odisha, India in 2018 to support India's malaria elimination efforts. Abbott contributed diagnostic test training for community health workers, product donations, and technical capacity support.
- PATH (PMI REACH Malaria Project)coreMalaria No More publishes stories on behalf of the PMI REACH Malaria Project, implemented by PATH, which supports community health worker training, seasonal malaria chemoprevention (SMC) campaigns, and malaria diagnosis improvement programs in Cameroon, Mali, Ghana, Malawi, and Kenya.
- U.S. President's Malaria Initiative (PMI)coreMalaria No More works closely with PMI to advocate for sustained U.S. funding, support program implementation through partners like PATH, and amplify PMI's impact in malaria-endemic countries.
- Global Fund to Fight AIDS, Tuberculosis and MalariacoreMalaria No More advocates for sustained U.S. contributions to the Global Fund and supports the Fund's programs and replenishment efforts. The Global Fund has saved 70 million lives and helped eliminate malaria in 21 countries.
- Health Finance Coalition (HFC)majorMalaria No More and HFC, led by CEO Martin Edlund, co-signed the ADB ExCITD partnership and collaborate on mobilizing catalytic capital financing for disease elimination in Asia-Pacific.
- Institute for Health Modeling and Climate Solutions (IMACS)coreIMACS is hosted by Malaria No More and serves as a center of excellence for AI-powered predictive intelligence at the intersection of climate change and infectious diseases. IMACS develops tools including the SPECTRA forecasting model and Climate-Informed Early Warning Surveillance Systems.
- Government of Bangladesh (National Malaria Elimination Program)majorIMACS partnered with Bangladesh's National Malaria Elimination Program to build a Climate-Informed Early Warning Surveillance System powered by AI for malaria, dengue, and acute waterborne diarrhea. The program also involves the Institute of Epidemiology, Disease Control and Research, Bangladesh Meteorological Department, and BRAC.
- World Health Organization (WHO)majorMalaria No More aligns its advocacy and programs with WHO guidelines and recommendations, including malaria vaccine rollout guidance and the World Malaria Report. WHO's SPECTRA recognition in the AI Health Use Cases Casebook validates IMACS's modeling work.
- UNICEFmajorMalaria No More collaborates with UNICEF on malaria programming, including a story featuring Ida Marie Ameda, UNICEF's Global Technical Lead for Malaria and NTDs, discussing the impact of conflict and displacement on malaria elimination.
- RBM Partnership to End MalariamajorMalaria No More partners with the RBM Partnership to End Malaria, co-hosting events such as the WHA79 side event and collaborating on advocacy and communications.
- African Leaders Malaria Alliance (ALMA)majorMalaria No More partnered with ALMA for the TICAD9 session 'Tackling Africa's Malaria Crisis,' marking malaria's first official topic at the Tokyo International Conference on African Development.
- Malaria No More JapanminorMalaria No More Japan partnered with Malaria No More to co-organize the TICAD9 thematic session on malaria, representing a regional affiliate organization.
- Corporate Council on Africa (CCA)minorMalaria No More partnered with the Corporate Council on Africa to analyze how malaria shapes the investment landscape for U.S. companies, highlighting $4 trillion in potential economic output linked to malaria goals.
- Hudson InstituteminorMalaria No More participated in a Hudson Institute panel discussion on 'Winning the Fight: How Ending Malaria Advances American Interests,' featuring former US Global Malaria Coordinator Ken Staley and former Rep. Ted Yoho.
- SC JohnsonmajorMalaria No More highlighted SC Johnson's Guardian™ Spatial Repellent as a breakthrough vector control tool. The State Department and Global Fund agreed to procure Guardian™ spatial repellents, with Malaria No More issuing a statement supporting the agreement.
- Target MalariamajorTarget Malaria, working with CDC and CDC Foundation, is advancing gene drive technologies to reduce malaria-transmitting mosquito populations. Malaria No More featured Target Malaria's work, including an interview with entomologist Krystal Birungi, a 2025 Gates Goalkeepers Champion.
- Medicines for Malaria Venture (MMV)majorMMV is pioneering a long-acting injectable for malaria prevention. Malaria No More highlighted MMV's work at the WHA79 event, noting its collaboration with Oregon Health & Science University and Calibr-Skaggs Institute.
- NovartismajorNovartis announced Phase III trial results for ganaplacide/lumefantrine (novel antimalarial with ingredient discovered in California) and WHO prequalification of Coartem® Baby, the first antimalarial developed for newborns. Malaria No More highlighted Novartis's contributions at WHA79.
- BASF Public HealthmajorBASF Public Health developed the Interceptor® G2 dual active ingredient bed net, shown in randomized control trials to cut malaria cases in half. PMI and CDC supported its development, and Malaria No More showcased it as a next-generation tool.
- Sanaria, Inc.majorMaryland-based Sanaria is developing groundbreaking malaria vaccines. Its PfSPZ-LARC2 Vaccine achieved 90% protection against controlled human malaria infection in a single dose, highlighted by Malaria No More.
- Thermo Fisher ScientificminorThermo Fisher Scientific (Massachusetts) developed a real-time PCR solution for malaria detection, offering accurate identification and quantification of malaria parasites. Featured in Malaria No More's American-Led Innovation showcase.
- Ifakara Health InstituteminorMalaria No More featured research from Tanzania's Ifakara Health Institute on genomics and malaria control, including a discussion with Dr. Fredros Okumu and Sophia Mwinyi on using advanced sequencing to identify a new mosquito species (Pwani molecular form).
- Wellcome Sanger InstituteminorThe Wellcome Sanger Institute collaborated with Ifakara Health Institute and University of Glasgow on advanced genomic sequencing that discovered a new mosquito species, with Malaria No More featuring the research.
- University of GlasgowminorUniversity of Glasgow's Professor Fredros Okumu (formerly of Ifakara Health Institute) collaborates on malaria genomics research featured by Malaria No More, investigating mosquito genetics and malaria vector control.
- Government of India / Ministry of HealthcoreThe Government of India's Ministry of Health is the counterpart for Malaria No More's partnership with Abbott in Odisha state, supporting India's goal to eliminate malaria by 2030. India reduced malaria cases from 2 million to 1.1 million over 15 years.
Scale indicators12 records
Recent moves6 records
Expansion highlights6 records
Malaria No More competitors and assessment
Company assessmentDirect peers
- PATH: Global health nonprofit that designs and delivers malaria and other disease solutions; a core implementation partner of Malaria No More (PMI REACH Malaria) and operates the same donor-funded, country-level delivery model.
- Nothing But Nets: UN Foundation-affiliated advocacy campaign focused on malaria prevention through bed-net distribution; operates with a similar advocacy-plus-fundraising model targeting U.S. policymakers and the general public.
- Gavi, the Vaccine Alliance: Public-private global health alliance focused on immunization access, including the new malaria vaccine rollout; shares MNM's PPP structure, donor-government advocacy, and country-level delivery model.
- Clinton Health Access Initiative (CHAI): Global health nonprofit that negotiates pricing, scales tools, and works with ministries of health on malaria and other diseases; comparable operating model of donor-funded, country-embedded program support.
- RBM Partnership to End Malaria: Multi-stakeholder global platform coordinating malaria actors; Malaria No More is a core partner and co-hosts convenings such as the WHA79 side event with RBM.
- Medicines for Malaria Venture (MMV): Product development partnership working on next-generation antimalarials; a Malaria No More partner showcased at WHA79 with a comparable donor-supported, mission-driven model.
Broad incumbents
- Global Fund to Fight AIDS, Tuberculosis and Malaria: Multilateral financing mechanism that Malaria No More advocates with; serves as the dominant pooled-funding channel for malaria programs and is a primary counterpart in MNM's advocacy wins.
- UNICEF: UN agency delivering child-health and malaria programs at scale; a key MNM implementation partner and the broader institutional counterpart for many of the same donor governments.
Regional players
- Asia Pacific Leaders Malaria Alliance (APLMA): Asia-Pacific malaria elimination alliance of heads of government; overlapping with MNM's Asia-Pacific expansion and the ExCITD/ADB partnership focused on regional financing and policy.
- African Leaders Malaria Alliance (ALMA): African Union-affiliated platform for heads of state on malaria; co-partnered with MNM on the TICAD9 session and shares the continental advocacy and accountability mission.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Malaria No More social profiles
Digital presenceMalaria No More financial estimates
Financial estimateRevenue estimate
Valuation estimate
Malaria No More leadership team
Management profileNumber of profiles
Profiles4 records
Malaria No More subsidiaries and ownership
Company hierarchySubsidiaries3 records
Malaria No More funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Malaria No More M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Malaria No More
What does Malaria No More do?
Malaria No More is a 501(c)(3) nonprofit advocacy organization that mobilizes political commitment, funding, and innovation to end malaria. It delivers U.S. and global policy advocacy, strategic communications campaigns, field implementation support (such as PMI REACH), and operates the IMACS technology platform with the SPECTRA AI forecasting model and Climate-Informed Early Warning Surveillance Systems to accelerate malaria elimination in endemic countries.
Is Malaria No More a public or private company?
Malaria No More is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Malaria No More founded?
Malaria No More was founded in 2006. It employs 11 to 50 people.
Where is Malaria No More based?
Malaria No More is headquartered in New York, United States, in the North America region.
How does Malaria No More make money?
Two revenue lines are on record. Tax-Deductible Donations are the primary driver. The others are government and Institutional Grants.
Who are Malaria No More's main competitors?
Direct peers on record are PATH, Nothing But Nets, Gavi, the Vaccine Alliance, Clinton Health Access Initiative (CHAI), RBM Partnership to End Malaria and Medicines for Malaria Venture (MMV). Broad incumbents are Global Fund to Fight AIDS, Tuberculosis and Malaria and UNICEF. Regional players are Asia Pacific Leaders Malaria Alliance (APLMA) and African Leaders Malaria Alliance (ALMA).
Does Malaria No More have an API?
No public API is recorded for Malaria No More.
What industry is Malaria No More in?
Malaria No More's product category is Global Health Advocacy. Its primary akta.pro industry code is HLAJAOAE, Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs), with a secondary code of HLAJAKAF, Disease-Specific Global Programs (HIV/TB/Malaria/NTDs). Its NAICS code is 813212 and its SIC code is 8600.